Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review.

Journal of the International AIDS Society - 1 Jan 2014

Bhargava Madhavi, Cajas Jorge Martinez, Wainberg Mark A, Klein Marina B, Pant Pai Nitika

Abstract excerpt

There are 31 million adults living with HIV-1 non-B subtypes globally, and about 10 million are on antiretroviral therapy (ART). Global evidence to guide clinical practice on ART response in HIV-1 non-B subtypes remains limited. We systematically searched 11 databases for the period 1996 to 2013...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Disease Progression
Share to Drug Resistance, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to Mutation

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 24998532
DOI: 10.7448/IAS.17.1.18944
PMCID: PMC4083185

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-24998532-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review.PMID 24998532Read ↗

Does genetic diversity of HIV-1 non-B subtypes differentially impact disease progression in treatment-naive HIV-1-infected individuals? A systematic review of evidence: 1996-2010.Semantic proximity Read ↗

HIV-1 Genetic Variability and Clinical ImplicationsSemantic proximity Read ↗

Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.Semantic proximity Read ↗

HIV-1 subtypes: epidemiology and significance for HIV managementSemantic proximity Read ↗

Transmitted Drug Resistance in Nonsubtype B HIV-1 InfectionSemantic proximity Read ↗

Drug resistance in non-subtype B HIV-1.Semantic proximity Read ↗

HIV Genetic Diversity and Drug ResistanceSemantic proximity Read ↗

Role of HIV Subtype Diversity in the Development of Resistance to Antiviral DrugsSemantic proximity Read ↗

Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy.Semantic proximity Read ↗

Role of genetic diversity amongst HIV-1 non-B subtypes in drug resistance: a systematic review of virologic and biochemical evidence.Semantic proximity Read ↗

Brief Communication: Impact of Pretreatment HIV-1 Drug Resistance on Virologic Outcomes in Ugandan Patients infected with Non-B HIV-1 SubtypesSemantic proximity Read ↗

Impact of HIV-1 pol diversity on drug resistance and its clinical implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.